DBV Technologies SA logo

DBV Technologies SA

NEW
CHIX:DBVp (France)   Ordinary Shares
€ 2.912 (0%) Jun 29
At Loss
P/B:
4.71
Market Cap:
€ 847.55M ($ 981.13M)
Enterprise V:
€ 651.64M ($ 754.35M)
Volume:
0
Avg Vol (2M):
702.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
702.00

Business Description

Description
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
Name Current Vs Industry Vs History
Cash-To-Debt
37.58
Equity-to-Asset
0.78
Debt-to-Equity
0.03
Debt-to-EBITDA
-0.04
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
1.39
9-Day RSI
5.83
14-Day RSI
9.26
3-1 Month Momentum %
-12.64
6-1 Month Momentum %
-12.88
12-1 Month Momentum %
-10.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.76
Quick Ratio
4.76
Cash Ratio
4.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-35.8
Shareholder Yield %
-37.02
Name Current Vs Industry Vs History
ROE %
-161.28
ROA %
-103.57
ROIC %
-528.4
3-Year ROIIC %
773.09
ROC (Joel Greenblatt) %
-1056.75
ROCE %
-151.23
Moat Score
4
Tariff Resilience Score
6

Financials (Next Earnings Date:2026-07-29 Est.)

CHIX:DBVp's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

DBV Technologies SA Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.764
Beta 0.4238
3-Year Sharpe Ratio 0.2
3-Year Sortino Ratio 0.5
Volatility % 148.47
14-Day RSI 9.26
14-Day ATR (€) 0.020142
20-Day SMA (€) 3.0747
12-1 Month Momentum % -10.48
52-Week Range (€) 1.604 - 3.97
Shares Outstanding (Mil) 295.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DBV Technologies SA Filings

Filing Date Document Date Form
No Filing Data

DBV Technologies SA Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings results for 2026 2026-10-28 In 120 days
Second quarter earnings results for 2026 2026-07-29 In 29 days
Goldman Sachs 47th Annual Global Healthcare Conference 2026-06-09 09:20 3.23 (+0.00%)
General meeting for 2026 2026-06-03 10:00 3.23 (+0.00%)
H.C. Wainwright 4th Annual BioConnect Investor Conference 2026-05-19 09:00 3.70 (+0.00%)
First quarter earnings results for 2026 2026-04-30 3.70 (+0.00%)
Annual report for 2025 2026-03-26 3.70 (+0.00%)
Fourth quarter earnings results for 2025 2026-03-26 3.70 (+0.00%)
Citizens Life Sciences Conference 2026-03-10 13:40 3.70 (+0.00%)
Guggenheim Securities Emerging Outlook: Biotech Summit 2026-02-12 14:30 3.97 (+0.00%)
Show
Entries

DBV Technologies SA Frequently Asked Questions

What is DBV Technologies SA(CHIX:DBVp)'s stock price today?
The current price of CHIX:DBVp is €2.91. The 52 week high of CHIX:DBVp is €3.97 and 52 week low is €1.60.
When is next earnings date of DBV Technologies SA(CHIX:DBVp)?
The next earnings date of DBV Technologies SA(CHIX:DBVp) is 2026-07-29 Est..
Does DBV Technologies SA(CHIX:DBVp) pay dividends? If so, how much?
DBV Technologies SA(CHIX:DBVp) does not pay dividend.

Articles on DBV Technologies SA

No articles.